Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.

Saved in:
Bibliographic Details
Title: Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.
Authors: Wu, Songtao1,2,3 (AUTHOR), Wang, Yingying2 (AUTHOR), Deng, Denghui2 (AUTHOR), Zheng, Guohua2 (AUTHOR), Mei, Hanxiang2 (AUTHOR), Wang, Cong2 (AUTHOR), Zheng, Xiang2 (AUTHOR), Gui, Chun2 (AUTHOR) 3001@hbucm.edu.cn, Liao, Fei4 (AUTHOR) feiliao@whu.edu.cn, Xiang, Meixian5 (AUTHOR) 756616131@qq.com
Source: Natural Products & Bioprospecting. 8/21/2025, Vol. 15 Issue 1, p1-19. 19p.
Database: Environment Complete
Full text is not displayed to guests.
Description
ISSN:21922209
DOI:10.1007/s13659-025-00540-9